Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration.
Abstract
BACKGROUND
The Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK) checklist consists of 20 items to report for published
tumor marker prognostic studies. It was developed to address widespread deficiencies in the reporting of such studies. In
this paper we expand on the REMARK checklist to enhance its use and effectiveness through better understanding of the intent
of each item and why the information is important to report.
METHODS
REMARK recommends including a transparent and full description of research goals and hypotheses, subject selection, specimen
and assay considerations, marker measurement methods, statistical design and analysis, and study results. Each checklist item
is explained and accompanied by published examples of good reporting, and relevant empirical evidence of the quality of reporting.
We give prominence to discussion of the 'REMARK profile', a suggested tabular format for summarizing key study details.
SUMMARY
The paper provides a comprehensive overview to educate on good reporting and provide a valuable reference for the many issues
to consider when designing, conducting, and analyzing tumor marker studies and prognostic studies in medicine in general.
To encourage dissemination of the Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and
Elaboration, this article has also been published in PLoS Medicine.
Links
Authors
Altman DG, McShane LM, Sauerbrei W, Taube SE
Institution
Centre for Statistics in Medicine, University of Oxford, UK. doug.altman@csm.ox.ac.uk
Source
BMC medicine 10: 2012 pg 51MeSH
AdultAged
Female
Humans
Male
Middle Aged
Neoplasms
Research Design
Tumor Markers, Biological
Pub Type(s)
Journal ArticleResearch Support, Non-U.S. Gov't
Language
eng
PubMed ID
22642691
Log In

